Jake Remaly

TOPLINE: Faricimab demonstrated a greater reduction in hard exudates than aflibercept in patients with diabetic macular edema (DME), according to research presented at EURETINA 2024.

CHICAGO —Among patients with medically intractable partial seizures who received treatment with a responsive cortical neurostimulator, the rate of sudden unexplained death in epilepsy (SUDEP) was lower than that estimated for patients with medically intractable epilepsy overall and for patients being considered for epilepsy surgery, according to research presented at the 140th Annual Meeting of the American Neurological Association. In addition, electrocorticographic data recorded by the neurostimulators indicate that SUDEP sometimes occurs after epileptiform discharges, such as spikes or electrographic seizures.

Major medical journals relied on peer reviewers who received more than $64 million in non-research payments between 2020 and 2022.

A lesional MRI, no history of generalization, and fewer prior resections may be associated with good outcomes.

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss anti-VEGF treatments.

SAN DIEGO —New or worse headaches may persist five years after traumatic brain injury (TBI), according to results of a prospective study presented at the 58th Annual Scientific Meeting of the American Headache Society. “Results suggest that ongoing assessment and treatment of headache after TBI is needed as headache remains a potential problem even five years post injury,” the researchers said.

TOPLINE: The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer.

More than half of the US peer reviewers for four major medical journals received industry payments between 2020-2022, new research shows. Altogether they received more than $64 million in general, non-research payments, with a median payment per physician of $7614. Research payments — including money paid directly to physicians as well as funds related to research for which a physician was registered as a principal investigator — exceeded $1 billion.

The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer. An analysis by Danish researchers found 14 extra cases of breast cancer per 10,000 women using this type of an intrauterine device (IUD) vs women not using hormonal contraceptives.

TOPLINE: Weight loss interventions using medication or behavioral changes can improve insulin resistance, hormonal markers, and menstrual